Monthly Archives: May 2010

Novartis Employees Get $250 million Payout

A Federal jury in New York ruled against Novartis in a gender discrimination lawsuit, ordering the company to pay $3.36 million in compensatory damages to 12 women and $250 million in punitive damages to 5,600 others in one of the largest gender discrimination class actions in American history. The women charged that Novartis created a […]
Posted in Corporate Responsibility, Legal, Sales | Tagged , , , , , , | Leave a comment

New FDA Campaign Targets Detailing, Trade Shows

In addition to sending out more warning letters and stepping up enforcement activity, the Food and Drug Administration wants health professionals to do more to police drug marketing and advertising. The agency’s “Bad Ad” program urges doctors and other health professionals to report any false or misleading ads or inappropriate marketing pitches. Depending on one’s […]
Posted in FDA, News, Regulatory | Tagged , , , , , , | Leave a comment

Judgment Day for Pfizer Factories

For once, pharma sales reps and R&D guys can breathe a sigh of relief. The latest round of industry layoffs comes from Pfizer, but this time it will affect the manufacturing force, which will be downsized by 6,000 employees by 2015. In 2006, the company announced plans to save $4 billion to $5 billion, and […]
Posted in Europe, Global, Manufacturing, News, Strategy | Tagged , , , , , , | Leave a comment

Astellas and OSI Come Together

The months-long saga is finally over: Astellas’ enhanced offer of $57.50 a share—around $4 billion—has finally netted it Melville, NY-based OSI Pharmaceuticals. The Japan-based pharma first extended an acquisition offer of $52 per share ($3.5 billion) to OSI on March 1, only to be met with a resounding “Nay” from the board, which said $52 […]
Posted in Deals, News, Strategy | Tagged , , , , , , | Leave a comment

TB Alliance Trumpets New, Improved Drugs at World Health Assembly

Like polio and leprosy, developed countries have long since tamed tuberculosis. But even now, other parts of the world continue to struggle against the disease, with nearly all (98 percent) of TB’s 1.7 million worldwide deaths occurring in developing countries. TB’s high comorbidity with HIV infections has recently added another level of urgency to efforts […]
Posted in Corporate Responsibility, Emerging Markets, Global, R&D | Tagged , , , , , , , , , , | Leave a comment
  • Categories

  • Meta